Disclosure Panels Details Page

Hepatobiliary Cancers Panel - Disclosures as of 02/17/2023

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Has Attended
Daniel Abbott MD None None Patient Point None
Thomas Abrams MD None None Eisai Inc.
Eli Lilly and Company
Exelixis Inc.
Ipsen
Merck & Co., Inc.
Biogen Idec|Guardant|Jounce
Aijaz Ahmed MD Intercept Gilead Sciences, Inc. Not Applicable Not Applicable -
Daniel Anaya MD DNAtrix Roche Laboratories, Inc. None None
Robert Anders MD, PhD Bristol Myers Squibb
Rapt Therapeutics
Standup 2 Cancer
Bristol Myers Squibb
Merck & Co., Inc.
None None -
Chandrakanth Are MBBS, MBA, FACS, FRCS None Basavatarakam Indo-American Cancer Hospital and Research Institute- started in February 2020 None None
Melinda Bachini None None AstraZeneca Pharmaceuticals LP
Boehringer Ingelheim GmbH
Incyte Corporation
Kinnate
National Cancer Institute
Taiho Pharmaceuticals Co., Ltd.
Tri-Salus
None
Al Benson III MD, FACCC, FACP, FASCO Astellas Pharma US, Inc.
Boehringer Ingelheim GmbH
Boston Scientific Corporation
Bristol Myers Squibb
GSK
Mirati
Mirati Therapeutics, Inc.
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Tempus
Terumo
Therabionic
Therabionic
Apexigen
Artemida
BioScend
Bristol Myers Squibb
Grail
HalioDx
Janssen Oncology
Merck Sharpe & Dohme
Natera
Pfizer Inc./Hospira Inc.
TUKYSA
Xencor
None None
David Binder MD None None None None
Marian Birkeland PhD None None None None -
Mitesh Borad MD None Genentech, Inc.
HUYA Bioscience International
Imvax
Lynx Group
Western Oncolytics
None None
Christopher Bowlus MD Boston Scientific Corporation
Bristol Myers Squibb
Calliditas
Chemomab
COUR
Cymabay
Genfit
Gilead Sciences, Inc.
GSK
Hanmi
Intercept
Mirum
Novartis Pharmaceuticals Corporation
Novo Nordisk
Pliant
Viking
None None None
Daniel Brown MD, FSIR None AstraZeneca Pharmaceuticals LP
Ipsen
Bard
Bright Research Partners
None -
Adam Burgoyne MD, PhD AstraZeneca Pharmaceuticals LP
Boston Scientific Corporation
Cogent Biosciences
Deciphera Pharmaceuticals, Inc.
Exelixis Inc.
Genentech, Inc.
Jiangsu Hengrui Medicine
Merck & Co., Inc.
Teclison
Tvardi Therapeutics
Deciphera Pharmaceuticals, Inc.
Exelixis Inc.
AstraZeneca Pharmaceuticals LP
Deciphera Pharmaceuticals, Inc.
None
Prabhleen Chahal MD Boston Scientific Corporation
Medtronic, Inc.
None None None -
Jordan Cloyd MD None None None None
Anne Covey MD None None None Amgen Inc.
Michael D'Angelica MD None None None None -
Tanya Fischer MEd, MLIS None None None None -
Evan Glazer MD, PhD, FACS Delcath Anviron None None
Kristina Gregory MSN, RN None None None None -
Evelyn Handel PharmD, BCOP, BCPS None None None None -
William Hawkins MD Celldex Therapeutics None None None -
Brianna Herron PharmD, BCOP, BCPS None None None None -
Cindy Hochstetler PhD None None None None -
Renuka Iyer MD AVEO Pharmaceuticals, Inc.
Ipsen
Lexicon Pharmaceuticals, Inc.
Merck & Co., Inc.
MimiVax, LLC
AstraZeneca Pharmaceuticals LP
Ipsen
Puma Biotechnology
Tersera
None None
Rojymon Jacob MD None None None None
Lawrence Jennings MD, PhD None None None None -
Robin Kelley MD Agios, Inc.
AstraZeneca Pharmaceuticals LP
Bayer HealthCare
Bristol Myers Squibb
Eli Lilly and Company
EMD Serono
Exelixis Inc.
Genentech, Inc.
LOXO
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Partner Therapeutics
QED
Relay Therapeutics
Surface Oncology
Taiho Pharmaceuticals Co., Ltd.
Agios, Inc.
AstraZeneca Pharmaceuticals LP
Exact Sciences
Exelixis Inc.
Genentech, Inc.
Ipsen
Kinnate
Merck & Co., Inc.
Relay Therapeutics
Servier
None None
Robin Kim MD None None None None -
Matthew Levine MD, PhD No commercial interest - institutionally funded clinical trial Expert witness - medical legal None None
Nicole McMillian MS None None None None -
Manisha Palta MD Merck & Co., Inc.
Varian Medical Systems, Inc.
Syntactx
UptoDate
Voxelmetric
None None
James Park MD None None None None
Sharon Park PharmD, BCOP None None None None -
Donna Powell DHSc, CMD, RT(T) None None None None -
Steven Raman MD Johnson & Johnson Otsuka America Pharmaceutical, Inc.
Profound
Bayer HealthCare Angiodynamics -
Sanjay Reddy MD, FACS None None None None
Vaibhav Sahai MBBS, MS Actuate Therapeutics
Agios, Inc.
Bristol Myers Squibb
Celgene Corporation
Clovis Oncology
Cornerstone
Exelixis Inc.
Fibrogen
Incyte Corporation
Ipsen
MedImmune Inc.
National Cancer Institute
Relay Therapeutics
Repare Therapeutics
Syros Pharmaceuticals
AstraZeneca Pharmaceuticals LP
Cornerstone Pharmaceuticals
Delcath Systems
GSK
Helsinn Therapeutics
Histosonics
Incyte Corporation
Ipsen
Kinnate
Lynx Group
Servier Pharmaceuticals
Taiho Pharmaceuticals Co., Ltd.
None Cornerstone Pharmaceuticals
Ryan Schonfeld BA None None None None -
Gagandeep Singh MD None None None None -
Stacey Stein MD None AstraZeneca Pharmaceuticals LP
Eisai Inc.
Exelixis Inc.
Genentech, Inc.
Imvax
Ipsen
Merck & Co., Inc.
QED
None None
Bettyanne Sunderland BSN, OCN None None None None -
Samantha Tamburro BSN, RN, OCN None None Flatiron Health, Inc. None -
Anita Turk MD Eli Lilly and Company None None None
Jean-Nicolas Vauthey MD None None None None
Alan Venook MD Amgen Inc.
Bridgebio
Amgen Inc.
Bristol Myers Squibb
Exact Sciences
Exelixis Inc.
GSK
Merck & Co., Inc.
Pfizer Inc.
None None -
Adam Yopp MD None None None None -